SavedAdd your journal

Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2020 / Cilt: 28 - Sayı: 2

Quality of life among patients with left ventricular assist device: Comparison of two populations

Sol ventrikül destek cihazlı hastalarda yaşam kalitesi: İki toplumun karşılaştırılması

Murat AVŞAR
Zeliha ÖZDEMİR KÖKEN
Sinan Sabit KOCABEYOĞLU
Ümit KRVAN
Mustafa PAÇ
Pages
308–314
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Turkish patients with left ventricular assist deviceshould be encouraged to adopt a more independent life, not tolimit their lives to home and to return to work according to theirfunctional capacity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: This study aims to evaluate quality of life amongpatients with an implanted left ventricular assist device in twodifferent populations.Methods: This cross-sectional study included a total of 20 patients(15 males, 5 females; mean age 41.8±13.4 years; range, 20 to 65years) from Turkey and 40 patients (33 males, 7 females; meanage 55.1±11.6 years; range, 21 to 76 years) from Germany whounderwent left ventricular assist device implantation and reachedtheir third month of treatment between January 2016 and August2016.
📊
Key Findings & Data:The Euro Quality of Life-5 Dimension Questionnaire andKansas City Cardiomyopathy Questionnaire-12 were used to assessquality of life of both groups.Results: Sixty-five percent of the German patients returned towork, while none of the Turkish patients returned after implantation(p=0.000).
💡
Conclusion & Impact:Turkish patients with left ventricular assist deviceshould be encouraged to adopt a more independent life, not tolimit their lives to home and to return to work according to theirfunctional capacity
🔬Design:Survey & Empirical Study
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: This study aims to evaluate quality of life amongpatients with an implanted left ventricular assist device in twodifferent populations.Methods: This cross-sectional study included a total of 20 patients(15 males, 5 females; mean age 41.8±13.4 years; range, 20 to 65years) from Turkey and 40 patients (33 males, 7 females; meanage 55.1±11.6 years; range, 21 to 76 years) from Germany whounderwent left ventricular assist device implantation and reachedtheir third month of treatment between January 2016 and August2016. The Euro Quality of Life-5 Dimension Questionnaire andKansas City Cardiomyopathy Questionnaire-12 were used to assessquality of life of both groups.Results: Sixty-five percent of the German patients returned towork, while none of the Turkish patients returned after implantation(p=0.000). The Turkish (70%) and German (40%) patients reportedthat they had difficulty in living with a left ventricular assistdevice (p=0.028). The mean Euro Quality of Life-5 DimensionQuestionnaire visual analog scale scores of the Turkish and Germanpatients were 70.50% and 62.38%, respectively. The mean KansasCity Cardiomyopathy Questionnaire-12 scores of the Turkish patientswere significantly higher than those of the German patients (p=0.01).Conclusion: Left ventricular assist device implantationimproved the quality of life of both Turkish and Germanpatients. Turkish patients with left ventricular assist deviceshould be encouraged to adopt a more independent life, not tolimit their lives to home and to return to work according to theirfunctional capacity

Özet

Amaç: Bu çalışmada iki farklı toplumda sol ventrikül destek cihazı takılan hastalarda yaşam kalitesi değerlendirildi. Ça­lış­ma pla­nı: Bu kesitsel çalışmaya Ocak 2016 ile Ağustos 2016 tarihleri arasında sol ventrikül destek cihazı takılan ve tedavinin üçüncü ayına ulaşan Türkiye’den toplam 20 hasta (15 erkek, 5 kadın; ort. yaş 41.8±13.4 yıl; dağılım, 20-65 yıl) ve Almanya’dan 40 hasta (33 erkek, 7 kadın; ort. yaş 55.2±11.6 yıl; dağılım, 21-76 yıl) alındı. Her iki grubun yaşam kalitesinin değerlendirilmesinde Avrupa Yaşam Kalitesi-5 Boyut Anketi ve Kansas City Kardiyomiyopati Anketi-12 kullanıldı. Bulgular: Alman hastaların %65’i implantasyon sonrasında işe geri dönerken, Türk hastaların hiçbiri işe geri dönmedi (p=0.000). Türk (%70) ve Alman (%40) hastalar sol ventrikül destek cihazı ile yaşamakta zorlandıklarını ifade etti (p=0.028). Avrupa Yaşam Kalitesi-5 Boyut Anketi görsel analog ölçeği skoru ortalaması Türk hastalarda %70.50, Alman hastalarda ise %62.38 idi. Kansas City Kardiyomiyopati Anketi-12 ortalama skoru, Alman hastalara kıyasla, Türk hastalarda anlamlı şekilde yüksek idi (p=0.01). So­nuç: Sol ventrikül destek cihazı implantasyonu Türk ve Alman hastaların her ikisinde de yaşam kalitesini iyileştirdi. Sol ventrikül destek cihazı olan Türk hastalar, daha bağımsız bir yaşamı benimseme, yaşantılarını ev ile sınırlandırmama ve fonksiyonel kapasiteleri doğrultusunda işe geri dönme konularında cesaretlendirilmelidir

🔖

Cite This Article

AVŞAR, M., KÖKEN, Z. Ö., KOCABEYOĞLU, S. S., KRVAN, Ü., PAÇ, M. (2022). Quality of life among patients with left ventricular assist device: Comparison of two populations. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 28 - Sayı: 2, 308–314. https://ajindex.com/articles/423711

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43
  2. Yılmaz MB, Akar RA, Ekmekçi A, Nalbantgil S, Sade LE, Eren M, et al. Future of advanced heart failure and mechanical support devices: A Cardiology-Cardiovascular Surgery Consensus Report. Turk Gogus Kalp Dama 2016;24:201-2
  3. Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011;30:402-7
  4. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS Annual Report:the evolution of destination therapy in the United States. J Heart Lung Transplant 2011;30:115-23
  5. Maciver J, Ross HJ. Quality of life and left ventricular assist device support. Circulation 2012;126:866-74
  6. Allen JG, Weiss ES, Schaffer JM, Patel ND, Ullrich SL, Russell SD, et al. Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant 2010;29:278-85
  7. Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant 2017;36:1080-6
  8. Jakovljevic DG, McDiarmid A, Hallsworth K, Seferovic PM, Ninkovic VM, Parry G, et al. Effect of left ventricular assist device implantation and heart transplantation on habitual physical activity and quality of life. Am J Cardiol 2014;114:88-93
  9. Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med 1969;62:989-93
  10. EQ-5D-3L Scale. Available at: http://www.euroqol.org/home. html. [Accessed: October, 2015
  11. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245-55
  12. Grady KL, Sherri W, Naftel DC, Myers S, Gelijins A, Moskowitz A, et al. Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support. J Heart Lung Transplant 2016;35:777-88
  13. Cook JL, Colvin M, Francis GS, Grady KL, Hoffman TM, Je